LIPOCINE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
LIPOCINE INC. (LPCN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2021-03-11
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $0.00.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2018-06-30 was $0.00.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-12-31 was $21.00K, a 89.18% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $1.00K.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $223.00K, a 3.24% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-11 | |||
| 2019-12-31 | $1.00K 10-K · filed 2021-03-11 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | $21.00K derived: sum of 3 quarters · filed 2019-05-08 | $92.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | $21.00K derived: sum of 2 quarters · filed 2019-05-08 | $92.00K derived: sum of 3 quarters · filed 2019-05-08 | $92.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $92.00K derived: sum of 2 quarters · filed 2019-03-06 | $92.00K derived: sum of 3 quarters · filed 2019-03-06 | $223.00K 10-K · filed 2019-03-06 |
| 2017-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $71.00K derived: sum of 2 quarters · filed 2018-11-07 | $202.00K 10-Q · filed 2018-11-07 | $396.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $131.00K 10-Q · filed 2018-08-07 | $325.00K derived: sum of 3 quarters · filed 2019-03-06 | $325.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $131.00K 10-Q · filed 2018-05-07 | $325.00K derived: sum of 2 quarters · filed 2019-03-06 | $325.00K derived: sum of 3 quarters · filed 2019-03-06 | $325.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $194.00K derived: sum of 2 quarters · filed 2019-03-06 | $194.00K derived: sum of 3 quarters · filed 2019-03-06 | $216.00K 10-K · filed 2019-03-06 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $22.00K 10-Q · filed 2017-11-08 | $22.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $22.00K 10-Q · filed 2017-08-07 | $22.00K derived: sum of 3 quarters · filed 2018-03-12 | $450.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $22.00K 10-Q · filed 2017-05-08 | $22.00K derived: sum of 2 quarters · filed 2018-03-12 | $450.00K derived: sum of 3 quarters · filed 2018-03-12 | $488.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $428.00K derived: sum of 2 quarters · filed 2018-03-12 | $466.00K derived: sum of 3 quarters · filed 2018-03-12 | $658.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $466.00K derived: sum of 2 quarters · filed 2016-11-08 | $658.00K 10-Q · filed 2016-11-08 | $658.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $230.00K 10-Q · filed 2016-08-09 | $230.00K derived: sum of 3 quarters · filed 2017-03-06 | $230.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $192.00K 10-Q · filed 2016-05-09 | $192.00K derived: sum of 2 quarters · filed 2017-03-06 | $192.00K derived: sum of 3 quarters · filed 2017-03-06 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $87.00K 10-K · filed 2017-03-06 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $87.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $87.00K 10-Q · filed 2015-08-11 | |||
| 2013-12-31 | $12.00K 10-K · filed 2015-03-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |